Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayOct 01, 2020 2:52 pm

Grey Cloak Tech Inc. (GRCK) is “One to Watch”

Actively executing its growth-by-acquisition strategy, building a portfolio of clinically proven, naturally formulated supplements The BergaMet NA brand is well-positioned for growth throughout North America with its proprietary 47% BPF formulations developed for cardiovascular health, women’s health, immune support, sports performance and recovery UBN subsidiary, with its KETONOMICS(R) proprietary formulation, is well-aligned with Grey Cloak’s corporate strategy to provide better lifestyles through superior health technology. KETONOMICS(R) is medical and scientific research that focuses on the field of brain and physiological metabolism which provides proprietary positions UBN has five unique formulation patents – one issued and four pending – targeting brain…

Continue Reading

ThursdayOct 01, 2020 1:55 pm

Pac Roots Cannabis Corp. (CSE: PACR) Adds 250 Acres of Premium Fraser Valley Land to Portfolio

PACR bought nine parcels comprising 250 acres of land in Fraser Valley, British Columbia Share purchase agreement worth $1.5 million cash plus 3 million common shares PACR leverages genetic technology to produce high-yield cannabinoid-specific cultivars that thrive in B.C. climate Pac Roots Cannabis (CSE: PACR), an innovative genetics-based cannabis company based in Canada, has just added 250 acres of premium Fraser Valley land to its portfolio. One of the most intensively farmed areas in Canada, the Fraser Valley generates the most significant farm income of any region in British Columbia. Boasting high-quality soils, a favorable climate, accessible water, and close…

Continue Reading

ThursdayOct 01, 2020 1:21 pm

Sugarmade Inc. (SGMD) Garners Accolades by BudCars CEO on Top Cannabis Nationwide Radio Show

BudCars CEO featured guest during “Cannabis Talk 101” show SGMD partnership allowed company to “focus on growth” Walker recognizes Sugarmade’s great accounting, management team The history and future of BudCars Cannabis Delivery Service was spotlighted during a recent “Cannabis Talk 101” episode. BudCars founder and CEO Clinton Walker was a featured guest on the global podcast, which is broadcast on major media networks and top podcast distribution hubs. The impressive potential for BudCars bodes well for Sugarmade (OTCQB: SGMD), which has invested in the burgeoning business. “We are a Northern California premier cannabis delivery [service],” explained Walker, during the program.…

Continue Reading

ThursdayOct 01, 2020 9:00 am

New Products, Programs in Smoking Cessation Sector Offer Hope, Support to Those Desperate to Quit

NetworkNewsWire Editorial Coverage: Smoking is the leading cause of preventable death in the world today. Globally, 7 million people die every year from tobacco use, and the number is projected to increase to 8 million if the pattern of smoking doesn’t change. These disturbing statistics are being noted by companies with experience and interest in working to make a difference in the world and provide effective ways to support and help smokers quit. One of those companies, Kaival Brands Innovations Group Inc. (OTCQB: KAVL) (KAVL Profile), recently announced it had acquired a patent for a synthetic nicotine and synthetic nicotine…

Continue Reading

WednesdaySep 30, 2020 3:05 pm

Kaival Brands Innovations Group Inc. (KAVL) Releases Q3 Numbers, Revenues up by 44%

Q3 2020 revenue numbers paint a bright future for KAVL with revenue up by approximately 44% Company closely focused on expanding distribution into large national retailers, convenience chains during Q4 Much of Q3 activity centered around Bidi(TM) Sticks Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, recently released its Q3 financial report. The report showed revenues for KAVL up by approximately 44% compared to Q2 2020. In addition, the report noted that national distribution channels are being established for future growth. “We had an extremely busy and…

Continue Reading

WednesdaySep 30, 2020 2:30 pm

Pure Extract Poised to Benefit as Mainstream Society Embraces Functional Mushrooms

Following $1.25 million donation, UC Berkeley launching Center for the Science of Psychedelics Pure Extract Technologies Inc. expanding into functional and medicinal mushroom market Psychedelic compounds increasingly being studied to treat wide range of physical, mental conditions Pure Extracts plans to obtain a Natural Health Products Site License from Health Canada to buy, sell, functional mushroom products For hundreds of years, medicinal mushrooms have been revered among both ancient and modern cultures throughout the world for their nutritional and medicinal qualities. Pure Extract Technologies, a private plant-based Canadian extraction company headquartered in British Columbia, is leveraging the latest in science…

Continue Reading

WednesdaySep 30, 2020 9:51 am

Crypto Millions Lotto named “Official Online Lottery Partner” of Serie A Club Atalanta B.C.

Crypto Millions Lotto, the world’s biggest digital lottery, has been named as the Official Online Lottery Partner of Italian Serie A club Atalanta B.C. It’s the first-ever partnership between an online lottery and a Serie A club. A coming together of two organisations, rising stars in different industries, that share the same bold approach. Professional football club in Italy forms partnership with world’s biggest digital lottery Crypto Millions Lotto named Official Online Lottery PartnerBoth organisations are known for punching above their weight. Crypto Millions Lotto disrupts traditional lotteries by offering jackpots many times larger than their more established national competitors. Atalanta B.C.…

Continue Reading

WednesdaySep 30, 2020 9:00 am

Solving One of the Largest Drivers of Disease: Inflammation

NetworkNewsWire Editorial Coverage: Inflammation typically occurs in the body as a natural response to threats such as infection or injury, but chronic inflammation can cause severe damage and even death. Inflammation is a well-known symptom of multiple infectious diseases. However, multidiscipline research strongly suggests that inflammation is also closely linked with a broad range of noninfectious diseases. The critical aspects of the interplay between inflammation and disease may well be the key to development of a new generation of drugs to treat previously untreatable diseases, sparking a flurry of biotech research and development in the field. At the vanguard of…

Continue Reading

TuesdaySep 29, 2020 1:30 pm

Predictive Oncology Inc. (NASDAQ: POAI) Set to Capitalize on Increased AI Usage within Oncological Treatments

Predictive Oncology develops AI-solutions designed to assist clinicians in formulating personalized treatment plans for oncological patients Artificial Intelligence is being increasingly used to help understand and accurately predict how drug therapies can interact with specific patients POAI’s TumorGenesis subsidiary is also creating laboratory-grown tumors to help clinicians and researchers to better test therapies Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, is set to play a key role as the integration of AI technology within cancer care continues to improve the accuracy and…

Continue Reading

TuesdaySep 29, 2020 12:37 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Scientific Advisory Board with Leading Neuro-Oncology Expert, Dr. Patrick Wen, M.D.

Pivotal Phase 2 Berubicin trial expected to commence in Q1 2021 following planned IND submission in Q4 2020 CNS Pharmaceuticals also plans to begin pre-clinical work on Berubicin in connection with treatment for lymphomas, pancreatic, and ovarian cancers Brain tumor drug therapeutics market expected to reach $3.4 billion by 2025 CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has expanded its Scientific Advisory Board by welcoming new member Dr. Patrick Wen, M.D., a leading neurology and neuro-oncology expert (http://nnw.fm/MSn9M). Dr. Wen joins current Board members,…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000